These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New agents that target senescent cells: the flavone, fisetin, and the BCL-X Zhu Y; Doornebal EJ; Pirtskhalava T; Giorgadze N; Wentworth M; Fuhrmann-Stroissnigg H; Niedernhofer LJ; Robbins PD; Tchkonia T; Kirkland JL Aging (Albany NY); 2017 Mar; 9(3):955-963. PubMed ID: 28273655 [TBL] [Abstract][Full Text] [Related]
4. Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity. He Y; Zhang X; Chang J; Kim HN; Zhang P; Wang Y; Khan S; Liu X; Zhang X; Lv D; Song L; Li W; Thummuri D; Yuan Y; Wiegand JS; Ortiz YT; Budamagunta V; Elisseeff JH; Campisi J; Almeida M; Zheng G; Zhou D Nat Commun; 2020 Apr; 11(1):1996. PubMed ID: 32332723 [TBL] [Abstract][Full Text] [Related]
5. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Zhu Y; Tchkonia T; Fuhrmann-Stroissnigg H; Dai HM; Ling YY; Stout MB; Pirtskhalava T; Giorgadze N; Johnson KO; Giles CB; Wren JD; Niedernhofer LJ; Robbins PD; Kirkland JL Aging Cell; 2016 Jun; 15(3):428-35. PubMed ID: 26711051 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Bcl-2/xl With ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in Mice. Pan J; Li D; Xu Y; Zhang J; Wang Y; Chen M; Lin S; Huang L; Chung EJ; Citrin DE; Wang Y; Hauer-Jensen M; Zhou D; Meng A Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):353-361. PubMed ID: 28479002 [TBL] [Abstract][Full Text] [Related]
7. Depletion of senescent-like neuronal cells alleviates cisplatin-induced peripheral neuropathy in mice. Acklin S; Zhang M; Du W; Zhao X; Plotkin M; Chang J; Campisi J; Zhou D; Xia F Sci Rep; 2020 Aug; 10(1):14170. PubMed ID: 32843706 [TBL] [Abstract][Full Text] [Related]
8. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Yosef R; Pilpel N; Tokarsky-Amiel R; Biran A; Ovadya Y; Cohen S; Vadai E; Dassa L; Shahar E; Condiotti R; Ben-Porath I; Krizhanovsky V Nat Commun; 2016 Apr; 7():11190. PubMed ID: 27048913 [TBL] [Abstract][Full Text] [Related]
9. Treatment with the BCL-2/BCL-xL inhibitor senolytic drug ABT263/Navitoclax improves functional hyperemia in aged mice. Tarantini S; Balasubramanian P; Delfavero J; Csipo T; Yabluchanskiy A; Kiss T; Nyúl-Tóth Á; Mukli P; Toth P; Ahire C; Ungvari A; Benyo Z; Csiszar A; Ungvari Z Geroscience; 2021 Oct; 43(5):2427-2440. PubMed ID: 34427858 [TBL] [Abstract][Full Text] [Related]
10. Discovery of piperlongumine as a potential novel lead for the development of senolytic agents. Wang Y; Chang J; Liu X; Zhang X; Zhang S; Zhang X; Zhou D; Zheng G Aging (Albany NY); 2016 Nov; 8(11):2915-2926. PubMed ID: 27913811 [TBL] [Abstract][Full Text] [Related]
13. The curcumin analog EF24 is a novel senolytic agent. Li W; He Y; Zhang R; Zheng G; Zhou D Aging (Albany NY); 2019 Jan; 11(2):771-782. PubMed ID: 30694217 [TBL] [Abstract][Full Text] [Related]
14. The senolytic agent ABT263 ameliorates osteoporosis caused by active vitamin D insufficiency through selective clearance of senescent skeletal cells. Yang C; Qiao W; Xue Q; Goltzman D; Miao D; Dong Z J Orthop Translat; 2024 Nov; 49():107-118. PubMed ID: 39430127 [TBL] [Abstract][Full Text] [Related]
15. Cycloastragenol: A Novel Senolytic Agent That Induces Senescent Cell Apoptosis and Restores Physical Function in TBI-Aged Mice. Zhang Y; Gao D; Yuan Y; Zheng R; Sun M; Jia S; Liu J Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047529 [TBL] [Abstract][Full Text] [Related]
16. ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein. Wang G; Zhan Y; Wang H; Li W Cancer Chemother Pharmacol; 2012 Mar; 69(3):799-805. PubMed ID: 22037880 [TBL] [Abstract][Full Text] [Related]
17. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448 [TBL] [Abstract][Full Text] [Related]
19. Nucleostemin is indispensable for the maintenance and genetic stability of hematopoietic stem cells. Yamashita M; Nitta E; Nagamatsu G; Ikushima YM; Hosokawa K; Arai F; Suda T Biochem Biophys Res Commun; 2013 Nov; 441(1):196-201. PubMed ID: 24140061 [TBL] [Abstract][Full Text] [Related]
20. [Experimental study of relationship between effect of ginsenoside Rg1 to delay hematopoietic stem cell senescence and expression of p16(INK4a)]. Zhou Y; Yang B; Yao X; Wang Y Zhongguo Zhong Yao Za Zhi; 2011 Mar; 36(5):608-13. PubMed ID: 21657082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]